scholarly journals Impact of Age, Tumor Size, Lymph Node Metastasis, Stage, Receptor Status and Menopausal Status on Overall Survival of Breast Cancer Patients in Pakistan

2015 ◽  
Vol 16 (3) ◽  
pp. 1019-1024 ◽  
Author(s):  
Humera Mahmood ◽  
Mohammad Faheem ◽  
Sana Mahmood ◽  
Maryam Sadiq ◽  
Javaid Irfan
Keyword(s):  
Breast Cancer ◽  
Overall Survival ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Tumor Size ◽  
Menopausal Status ◽  
Breast Cancer Patients ◽  
Receptor Status ◽  
Node Metastasis

Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients

2008 ◽  
Vol 134 (11) ◽  
pp. 1229-1235 ◽  
Author(s):  
Sebastian Mayer ◽  
Axel zur Hausen ◽  
Dirk Otto Watermann ◽  
Stefan Stamm ◽  
Markus Jäger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Tumor Size ◽  
Breast Cancer Patients ◽  
Node Metastasis ◽  
Soluble Cd44

scholarly journals Prognosis assessment of CD44+/CD24- in Breast Cancer Patients: a systematic review and meta-analysis

2021 ◽  
Author(s):  
Jingjing Gu ◽  
Dandan Chen ◽  
Zhiqiang li ◽  
Yongliang Yang ◽  
Zhaoming Ma ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Distant Metastasis ◽  
Tumor Size ◽  
Meta Analysis ◽  
Breast Cancer Patients ◽  
Clinical Prognosis ◽  
Node Metastasis

Abstract Purpose: This meta-analysis investigated the relationships between the CD44+/CD24- phenotype and tumor size, lymph node metastasis, distant metastasis, disease-free survival (DFS), and overall survival (OS) in 8036 postoperative breast cancer patients enrolled in 23 studies.Methods: A literature search of PubMed, Medline, Cochrane, Embase, and PMC was conducted to identify eligible studies. The combined odds ratios (ORs) and 95% confidence intervals (95%CIs) were analyzed to evaluate the relationships between the CD44+/CD24- phenotype and the pathological and biological characteristics of breast cancer patients, and the combined hazard ratios (HRs) and 95% CIs were calculated to evaluate the relationships between CD44+/CD24- and DFS and OS of breast cancer petients using Stata12.0 software.Results: The CD44+/CD24- phenotype were not related to the tumor size (tumor size > 2.0 cm vs ≤ 2.0 cm, combined OR = 0.98, 95%CI: 0.68–1.34, p = 0.792) and didn’t promote lymph node metastasis (lymph node metastasis vs. no lymph node metastasis, combined OR = 0.94, 95% CI: 0.71–1.26, p = 0.692) and distant metastasis (distant metastasis vs no distant metastasis, combined OR = 3.88, 95% CI: 0.93–16.24, p = 0.064). The CD44+/CD24- phenotype was negatively correlated with postoperative DFS (HR = 1.67, 95% CI: 1.35–2.07, p <0.00001) and OS (combined HR = 1.52, 95%CI: 1.21–1.91, p = 0.0004).Conclusion: These results suggested expression of the CD44+/CD24- phenotype can be used as a reliable indicator of clinical prognosis and a potential therapeutic targets in breastcancer patients.

The association of TINCR downregulation with tumor size of breast cancer patients and its lymph node metastasis

2021 ◽  
Vol 12 (3) ◽  
pp. 146-153
Author(s):  
Z Shaghaghi Torkdari ◽  
M Khalaj-Kondori ◽  
MA Hosseinpour Feizi
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Tumor Size ◽  
Breast Cancer Patients ◽  
Node Metastasis

scholarly journals Aberrant plasma levels of circulatingmiR-16, miR-107, miR-130aandmiR-146aare associated with lymph node metastasis and receptor status of breast cancer patients

Oncotarget ◽  
2015 ◽  
Vol 6 (15) ◽  
pp. 13387-13401 ◽  
Author(s):  
Isabel Stückrath ◽  
Brigitte Rack ◽  
Wolfgang Janni ◽  
Bernadette Jäger ◽  
Klaus Pantel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Plasma Levels ◽  
Breast Cancer Patients ◽  
Receptor Status ◽  
Node Metastasis

scholarly journals Can primary breast cancer patients sense the presence of lymph node metastasis? An unexpected research finding

1998 ◽  
Vol 52 (3) ◽  
pp. 363-364 ◽  
Author(s):  
Bert De Brabander ◽  
Pol Gerits ◽  
Robert Sacré ◽  
Jan Lamote
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Primary Breast Cancer ◽  
Research Finding ◽  
Breast Cancer Patients ◽  
Node Metastasis

IV-DSA is a new diagnostic tool for axillary lymph node metastasis in breast cancer patients

2004 ◽  
Vol 87 (2) ◽  
pp. 75-79 ◽  
Author(s):  
Osamu Watanabe ◽  
Tadao Shimizu ◽  
Hiroshi Imamura ◽  
Jun Kinoshita ◽  
Yoshihito Utada ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Diagnostic Tool ◽  
Axillary Lymph Node ◽  
Axillary Lymph Node Metastasis ◽  
Axillary Lymph ◽  
Breast Cancer Patients ◽  
Node Metastasis

scholarly journals Comparison between surgery plus radiotherapy and radiotherapy alone in treating breast cancer patients with ipsilateral supraclavicular lymph node metastasis

Gland Surgery ◽  
2020 ◽  
Vol 9 (5) ◽  
pp. 1513-1520
Author(s):  
Xian-Fu Sun ◽  
Ying-Jie Wang ◽  
Tao Huang ◽  
Lian-Jie Niu ◽  
Qiang Zhang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Supraclavicular Lymph Node ◽  
Node Metastasis ◽  
Supraclavicular Lymph Node Metastasis ◽  
Radiotherapy Alone

Combined 68Ga-NOTA-Evans Blue Lymphoscintigraphy and 68Ga-NOTA-RM26 PET/CT Evaluation of Sentinel Lymph Node Metastasis in Breast Cancer Patients

2019 ◽  
Vol 31 (2) ◽  
pp. 396-403 ◽  
Author(s):  
Jie Zang ◽  
Qingxing Liu ◽  
Huimin Sui ◽  
Hua Guo ◽  
Li Peng ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Lymph Node Metastasis ◽  
Cancer Patients ◽  
Evans Blue ◽  
Breast Cancer Patients ◽  
Node Metastasis ◽  
Pet Ct ◽  
Ct Evaluation
Sign in / Sign up

Export Citation Format

Share Document